Potential ALS treatment may repair axons of diseased neurons

by admin | Jun 5, 2022 | Blog, Clinical trials, The Brain

... Read More | Share it now!

Amylyx Pharmaceuticals Receives Notification of PDUFA Date Extension for AMX0035 for the Treatment of ALS

by admin | Jun 5, 2022 | Blog, Clinical trials

... Read More | Share it now!

NeuroSense Enrolls First Patient in Phase IIb ALS Trial for its Combination Therapy PrimeC

by admin | Jun 5, 2022 | Blog, Clinical trials

... Read More | Share it now!

Antisense oligonucleotide silencing

by admin | Jun 5, 2022 | Blog, Clinical trials, News

... Read More | Share it now!

Ultomiris

by admin | Jun 2, 2022 | Clinical trials

... Read More | Share it now!

Tudca

by admin | Jun 2, 2022 | Blog, Clinical trials

... Read More | Share it now!